about
New and emerging yeast pathogensCandidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies.PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies.Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources.SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.Antibody response that protects against disseminated candidiasisAn observational study on the epidemiological and mycological profile of Candidemia in ICU patients.Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit.Nonculture methods for diagnosis of disseminated candidiasis.Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic Candida infections?Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species.Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card.Nanoparticle-Based Mycosis Vaccine.Nosocomial Candida guilliermondii fungemia in cancer patients.The cytokine stew and innate resistance to L. monocytogenes.Clinical presentation of invasive Candida mycoses.Strain typing and determination of population structure of Candida krusei by multilocus sequence typing.Candida carriage in the alimentary tract of liver transplant candidates.Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy.Adherence of Candida strains isolated from the human gastrointestinal tract.An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy
P2860
Q30452880-00515AF7-0D64-4C92-BACB-B24188EDE6CAQ33542339-83CE7C82-43F5-4542-A753-BE19FEE8F849Q33659899-BAC94112-C09B-4AEC-8EBA-75168BBE325FQ33960914-40C8E38A-ED49-47CB-ADB1-1653437083AEQ33977852-8692270F-0E10-45D4-8E71-3E0946883392Q34453558-2BA01451-9542-44FD-B008-382CF509E4BDQ35112747-968662D9-CAB7-40A7-B7B5-E8AFC02BBB06Q35424332-E1D8E150-996A-4159-8C0B-CFF3F1D319E9Q36516322-94C26B9A-CA2E-4BF5-B756-7EE8C3162344Q36526696-5D0F93C9-92F7-4898-A2D6-1E8B9CAA5779Q36640479-3849E077-E188-4CA1-A57C-4941CA42E872Q38561855-BB6F50A5-4BC6-48F8-B8D7-A30CD2C1CF54Q40011216-BF739A29-2BEC-4AC9-B3A5-D03A94F273F3Q40181124-0ED61EFE-C065-4D53-940C-A119534A1AEAQ40183778-0F7B5ED4-F1C7-4D13-BF95-E9E92417C9B7Q40621125-98A80CAA-D462-486F-A145-625D6B15B37BQ41603442-4590EAB9-9E63-4A74-A8DB-D73EC366F024Q41708343-4849BAC0-1D72-40DB-8107-B34DCD46C976Q41819710-CF2795A1-AAE1-4238-BC65-4E40FB950562Q42268428-D4A492E4-D548-4219-9B8A-2AD1CFA65BE6Q48224583-CFE9C991-BDEC-431A-BD0B-C885782DE105Q54718913-D4141797-D5EA-43C7-9249-B236696A6276Q58840045-17612BF2-15D4-47A6-A05C-11A1D65EF4BB
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Candidemia in immunocompromised patients.
@en
type
label
Candidemia in immunocompromised patients.
@en
prefLabel
Candidemia in immunocompromised patients.
@en
P2093
P1476
Candidemia in immunocompromised patients.
@en
P2093
P304
P356
10.1093/CLINIDS/14.SUPPLEMENT_1.S120
P407
P478
14 Suppl 1
P577
1992-03-01T00:00:00Z